Sign Up for a Free Account
  • Updated 12.28.2020
  • Released 03.30.1995
  • Expires For CME 12.28.2023

HMG-CoA lyase deficiency

Introduction

Overview

HMG-CoA lyase deficiency is an inborn error of metabolism resulting in impaired ketogenesis. The catabolism of leucine is also affected, and several metabolites accumulate that probably have toxic potential. The disease is characterized by life-threatening metabolic derangements with hypoketotic hypoglycemia and metabolic acidosis, often manifesting within the early neonatal period; the remainder of patients typically present within the first year of life. As with many other organic acidurias, in HMG-CoA lyase deficiency early diagnosis and early initiation of appropriate treatment appear important for a good outcome.

Key points

• Deficiency of 3-hydroxy-3-methylglutaryl coenzyme A lyase (HMG-CoA lyase) is an organic aciduria with impaired ketogenesis and leucine catabolism.

• HMG-CoA lyase deficiency is characterized by life-threatening metabolic derangement with hypoketotic hypoglycemia and metabolic acidosis.

• HMG-CoA lyase deficiency is an autosomal recessive disorder due to mutations in the HMGCL gene.

• Complications can probably be minimized by early diagnosis and appropriate treatment, including avoidance of prolonged fasting.

Historical note and terminology

3-hydroxy-3-methylglutaryl coenzyme A lyase (HMG-CoA lyase) catalyzes the final step of ketogenesis and leucine metabolism, the cleavage of HMG-CoA yielding acetyl-CoA and acetoacetate (32; 10; 33). Inborn deficiency of HMG-CoA lyase results in 3-hydroxy-3-methylglutaric aciduria. The first patient reported with HMG-CoA lyase deficiency was a boy who presented at 7 months of age with diarrhea and vomiting that were associated with lethargy, pallor, dehydration and events of cyanosis and apnea (07). Metabolic acidosis and hypoglycemia were noted and Reye syndrome was suspected. Urine samples obtained after clinical onset showed a pattern of organic acids with highly elevated concentrations of 3-hydroxy-iso-valeric, 3-methylglutaric, 3-methylglutaconic and 3-hydroxy-3-methylglutaric acids. The patient recovered completely after intensive care and several days of intravenous fluids. Several aspects of his metabolic disease (including confirmation of HMG-CoA lyase deficiency in skin fibroblasts and in leukocytes) and his further development have been addressed in a number of subsequent reports (08; 45; 41; 42; 43; 44; 34). At the age of 10 years he has been considered healthy on a self-regulated diet high in potatoes and citrus cordials. However, the boy lacked attention at school, required special teaching and has broken both arms a total of 9 times. Occasional attacks with lethargy, pallor, nausea and vomiting occur and are managed by supplementing glucose intake (44).

Start a MedLink Neurology trial
to unlock 3 free articles.

  • Nearly 3,000 illustrations, 
including video clips of 
neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of 
neurology in 1,200 
comprehensive articles.

Questions or Comment?

MedLink, LLC

10393 San Diego Mission Rd, Suite 120

San Diego, CA 92108-2134

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com